NASDAQ: MCRB
Seres Therapeutics Inc Stock Ownership - Who owns Seres Therapeutics?

Insider buying vs selling

Have Seres Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Matthew R. HennPres;CSci2026-11-16101$1.38
$139.38Sell
Eric D. ShaffDirector2026-11-16287$1.38
$396.06Sell
Thomas DesrosierCLO;EVP2026-11-16103$1.38
$142.14Sell
Kelly BradyCOO;EVP2026-11-1685$1.38
$117.30Sell
Eric D. ShaffDirector2026-08-17263$4.55
$1.20kSell
Matthew R. HennPres;CSci2026-08-1781$4.55
$368.55Sell
Kelly BradyCOO;EVP2026-08-1764$4.55
$291.20Sell
Thomas DesrosierCLO;EVP2026-08-1782$4.55
$373.10Sell
Kelly BradyChief Operating Officer EVP2026-05-1859$7.53
$444.27Sell
Thomas DesrosierEVP and Chief Legal Officer2026-05-1879$7.53
$594.87Sell

1 of 2

MCRB insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when MCRB insiders and whales buy or sell their stock.

MCRB Shareholders

What type of owners hold Seres Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Nutritional Health Ltp Fund General Partner LLC234.12%23,869,081$29.60MInsider
Sa Nestle214.61%21,879,753$27.13MInsider
Nestle Health Science Us Holdings Inc67.57%6,888,888$8.54MInsider
Flagship Pioneering Fund VII General Partner LLC57.14%5,825,495$7.22MInsider
Flagship Pioneering Inc43.59%4,444,444$5.51MInsider
Noubar Afeyan26.98%2,750,135$3.41MInsider
Flagship Ventures Fund IV General Partner LLC3.69%376,018$466.26kInsider
Roger Pomerantz2.10%213,976$265.33kInsider
David Arkowitz1.79%182,442$226.23kInsider
David N. Cook1.45%147,435$182.82kInsider

1 of 3

MCRB vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
MCRB0.00%100.00%Net SellingNet Selling
PASG0.00%100.00%Net Buying
NEUP0.03%99.97%
ALLR0.01%14.05%Net SellingNet Selling
BOLT0.00%100.00%Net BuyingNet Buying

Seres Therapeutics Stock Ownership FAQ

Who owns Seres Therapeutics?

Seres Therapeutics (NASDAQ: MCRB) is owned by 0.02% institutional shareholders, 658.50% Seres Therapeutics insiders, and 0.00% retail investors. Nutritional Health Ltp Fund General Partner LLC is the largest individual Seres Therapeutics shareholder, owning 23.87M shares representing 234.12% of the company. Nutritional Health Ltp Fund General Partner LLC's Seres Therapeutics shares are currently valued at $29.60M.

If you're new to stock investing, here's how to buy Seres Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.